| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |